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Abstract With a realistic threat against biodiversity
in rain forests and in the sea, a sustainable use of
natural products is becoming more and more impor-
tant. Basic research directed against different organ-
isms in Nature could reveal unexpected insights into
fundamental biological mechanisms but also new
pharmaceutical or biotechnological possibilities of
more immediate use. Many different strategies have
been used prospecting the biodiversity of Earth in the
search for novel structure–activity relationships,
which has resulted in important discoveries in drug
development. However, we believe that the develop-
ment of multidisciplinary incentives will be neces-
sary for a future successful exploration of Nature.
With this aim, one way would be a modernization and
renewal of a venerable proven interdisciplinary
science, Pharmacognosy, which represents an inte-
grated way of studying biological systems. This has
been demonstrated based on an explanatory model
where the different parts of the model are explained
by our ongoing research. Anti-inﬂammatory natural
products have been discovered based on ethnophar-
macological observations, marine sponges in cold
water have resulted in substances with ecological
impact, combinatory strategy of ecology and chem-
istry has revealed new insights into the biodiversity of
fungi, in depth studies of cyclic peptides (cyclotides)
has created new possibilities for engineering of
bioactive peptides, development of new strategies
using phylogeny and chemography has resulted in
new possibilities for navigating chemical and biolog-
ical space, and using bioinformatic tools for under-
standing of lateral gene transfer could provide
potential drug targets. A multidisciplinary subject
like Pharmacognosy, one of several scientiﬁc disci-
plines bridging biology and chemistry with medicine,
has a strategic position for studies of complex
scientiﬁc questions based on observations in Nature.
Furthermore, natural product research based on
intriguing scientiﬁc questions in Nature can be of
value to increase the attraction for young students in
modern life science.
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Modern life science
Many situations in the society of today have shown
the need for science to achieve a sustainable future
development. Among recent issues in this line we
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warming, such as the future demand of food and
fodder for life stock. Other important problems are
the threats against the biodiversity in the tropical rain
forests. This is also the case for shallow water coral
reefs and mangrove swamps, which are both
threatened by higher temperature and a lowered pH
due to an increase of carbon dioxide in the atmo-
sphere. Another serious development is the increas-
ing resistance of pathogenic bacteria against the
available antibiotic used in treating a number of
severe diseases.
In today’s society we see a renewed interest in
green chemistry and a sustainable use of natural
products. These tendencies are evident also in the
search for new pharmaceutical and biotechnological
possibilities, where the development of multidisci-
plinary incentives will probably be necessary. Such
multidisciplinary research, for example directed on
different organisms, could provide us with a more
complete picture of the complex workings of the
Earths biome, but also give unexpected insights into
fundamental biological mechanisms of more imme-
diate use.
Despite this, concern has been raised over the
lowered interest in pursuing higher education in
science among young people. In recent years the
European commission has been investigating atti-
tudes towards science and technology among Euro-
pean citizens. Their latest report ‘‘Young people and
Science’’ (EC 2008) summarizes ﬁndings from a
survey comprising interviews from close to 25,000
Europeans aged 15–25 from all 27 EU membership
states, probing the views and interest of young
citizens, regarding a future involvement in science
and technology. In general the report presented a
positive view concerning science and technology and
an awareness of the fact that science is important for
the development of the future society. However, in
the responders own selection of study objects for the
future, interest in natural science showed a surpris-
ingly low preference in comparison to that of social
sciences or economics.
This is daunting, as a future society will need
politicians and citizens that have enough scientiﬁc
knowledge to make critical decisions about important
questions such as global warming, rain forest
destruction, stem cell research, and nuclear power
waste.
Furthermore, it seems that the number of students
pursuing higher studies in basic science such as
physics, chemistry, and biology are decreasing, while
mirrored by an increased interest for applied aspects
such as environmental chemistry, material physics,
and biotechnology. The reason for a lowered interest
in basic science has been discussed in recent edito-
rials of the prestigious scientiﬁc journal Science
(Cech and Kennedy 2005; Augustine 2008). Concern
was raised about education methods and the failure to
encourage the students for a scientiﬁc career but also
about spreading knowledge about the importance of
basic science in society.
We would argue that the multidisciplinary subject
Pharmacognosy, as one of several scientiﬁc disci-
plines, has a strategic position in the studies of
scientiﬁc questions based on observations in Nature.
In addition to that, such a subject that itself is
bridging biology and chemistry with medicine can be
of value in the joint efforts to attract young students
for studies in modern life science.
Natural products in relation to modern life science
For centuries the human race has constructed inge-
nious devices to solve problems and make products
for our needs. Although this progress has resulted in
the present day wealth and prosperity, there has also
been another side to this, as discussed in the sections
above. With the increasing understanding of why we
ﬁnd ourselves in this predicament, it is not surprising
that along many paths of modern life science research
we ﬁnd attempts to understand and build on more
natural or environmental friendly methods. However,
the complexity of such development is shown by the
old use of fossil fuels, which transcended in a ﬁrst
hype of technologically trivial but energetically
unfavourable ethanol, and now exploring other paths
more in line with a sustainable development and
acceptable ethics. In the ﬁeld of pharmaceutics, the
synthetic chemistry of the twentieth century is
gradually made more efﬁcient and precise, but also
gradually changing into bio-technological applica-
tions and a return to the inﬁnitely more variable and
complex chemistry of Nature.
Organisms in Nature produce secondary metabo-
lites with the speciﬁc purpose to gain evolutionary
advantages in the competition for example living
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123space and in the search for nutrients. During evolu-
tion different enzymatic machineries have been
developed, which has directed the biosynthesis of
different molecular frameworks of secondary metab-
olites. With an estimated number of more than
300,000 species of plants and probably close to two
million species of fungi, insects, and various marine
organisms—not to mention bacteria—the biodiver-
sity of Nature remains an unparalleled reservoir of
biological and chemical diversity. However, most of
the biodiversity is as yet unexplored.
Several different strategies, based on ethnophar-
macological, ecological or toxicological observations
together with random screening, and more recently
phylogenetic frameworks, have been used in pros-
pecting this biodiversity in the search for unique
structure–activity relationships, and resulted in revo-
lutionary discoveries in medicine. The ethnopharma-
cological approach has been the platform for research
programs with the objective to study plants used in
traditional medicine in different cultures. With the
increased awareness of indigenous peoples rights to
their traditional knowledge, established in several
conventions, it has already become increasingly
complicated to perform and ﬁnance such research.
However, in the extension this will also develop more
respectful insights into sharing of resources and
traditional knowledge. Due to a very limited access
to marine organisms for people in old times few
reports exist where marine organisms have been used
in traditional medicine. Bio-prospecting the marine
environment is now rapidly expanding, in many cases
driven by ecological observations, and the number of
novel bioactive molecules isolated from marine
organisms is increasing. Of importance for future
natural products research is that in recent years
microorganisms found in or associated with marine
sponges have been shownto be the actual producers of
isolated novel compounds. This can result in new
methods for cultivation of these types of organisms as
a sustainable resource of the bioactive compound.
Modern biotechnology has developed new possi-
bilities and tools for elucidation of many biosynthetic
pathways for natural products where enzymes
involved have been isolated and characterized and
in some cases even cloning of the coding genes. This
development has created new strategies like combi-
natorial biosynthesis, which can lead to entirely new
classes of polyketides synthesized by very large
enzymes and non-ribosomal polypeptides. Another
possibility to create new chemical structures, based
on a natural scaffold, is the bioengineering of cyclic
peptides such as cyclotides. A natural cyclotide
consists of 28–37 conventional amino acids con-
nected by amide bonds to a cyclic ring stabilized by
three disulﬁde bridges which creates six loops of
different size. It has been demonstrated that the
amino acids in the different loops can be exchanged
for new amino acids and in this way novel structure–
activity relationships can be studied.
Instead of a speciﬁc observation in Nature, which
deﬁnes the scientiﬁc question and strategy for a
research project, extracts from randomly selected
organisms can be screened for a speciﬁc activity. This
approachhasbeen successful inthe discoveryof novel
antibiotics but less successful in other areas, even
when technologically advanced methods such as
combinatorialsynthesisandindustrialhighthroughput
screening have been applied. One reason is that such
endeavours soon become a numbers game, and hence
methods to limit the number of compounds for testing
and selecting the most promising candidates are
imperative. One way to decrease the complexity and
sizeofcompoundlibrariesnecessarytotransverseisto
apply tools such as chemography to navigate chemical
space (Oprea and Gottfries 2001). A recently
described tool able to handle also the complex
molecules of natural origin is the ChemGPS-NP
global map of the biologically relevant volumes of
multidimensional chemical property space. Combined
with phylogenetic studies, which applies to the
relationship of evolution of organisms, these methods
can be used in silico to explore and attempt to
understand how biosynthetic ability has developed
among different organisms. Understanding such pro-
cesses may lead to conceptually novel models for
prediction and selection of organisms that produce
compounds with speciﬁc biological activitybut also to
predict new targets, as discussed below.
A Linnaean view on science
There are many similarities with the present drive for
more applied research and utilizable results, with the
predominant views in the Linnaean eighteenth cen-
tury Europe. In that e ´poque the states and govern-
ments proved eager to explore Nature for its better
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123use. The way this was pursued was through intense
support of research funds to the universities, the
erection of governmental ofﬁces and boards to survey
and supervise mining, trade and agriculture—and as
we can see on the numerous TV shows with research
themes: a societal gloriﬁcation of scientists. The
major difference might be, that today the public
appears less impressed and eager to participate.
Perhaps the last centuries’ scientiﬁc and engineering
advances have made us less prone to marvel at novel
discoveries?
Linnaeus used a holistic approach in both his
teaching and research. Together with his students he
produced 186 theses during the years 1744–1776 in
many different disciplines for example De methodo
investigandi vires medicamentorum chemica (Regard-
ing the chemical method to investigate the virtues of
drugs) by Hiortzberg (1765). The multidisciplinary
approach is obvious in his Materia Medica, ﬁrst
published in 1749, where he applies a surprisingly
modern way of describing different aspects of medic-
inal plants and their preparation, use and effect.
Thunberg and Wahlenberg were the Linnaean
successors at Uppsala University, followed in 1893
by Rosendahl who was ﬁrst appointed to a chair in
general and experimental Pharmcodynamics with
Pharmacognosy. In the beginning of the twentieth
century Rosendahl became the ﬁrst Swedish profes-
sor in ‘‘Botany and Pharmacognosy’’ then afﬁliated to
the Royal Institute of Pharmacy in Stockholm.
During the ﬁrst part of the twentieth century the
Swedish education, training, and research in Phar-
macognosy was botanically oriented with a focus on
morphology and anatomy and the purpose of identi-
ﬁcation and quality control of crude drugs. During the
past 60 years the subject of Pharmacognosy has
developed towards a multidisciplinary scientiﬁc sub-
ject combining natural product chemistry with biol-
ogy, and since 1973 forms a part of the revived
Faculty of Pharmacy at Uppsala University.
Modern pharmacognosy—an integrated discipline
Most important in our research today is the develop-
ment of strategies for selection, isolation and charac-
terisation with the objective to discover unique
bioactive chemical structures with drug potential,
and to reveal unknown targets, by studying the
evolutionarystructure–activityoptimizationinNature.
In addition to the possibility to discover new drug
candidates for drug development, bioactive natural
projects have potential as pharmacological tools,
intermediates, or templates for synthesis of drugs.
The increased uses of herbal remedies, which contain
complex mixtures of natural products, need intensiﬁed
scientiﬁc studies to establish efﬁcacy and safety of
these types of products as well as clinical studies.
Thus, we would argue that our research represents
a modernization and renewal of a venerable proven
science, Pharmacognosy, without losing (or ignoring)
the traditions in the ﬁeld. With the increasing interest
for environmental aspects, green chemistry, and a
sustainable use of natural products, this renewal
could have a strategic position in bridging chemistry
and biology.
The interdisciplinary nature of the subject is
explained in the model below (Fig. 1) where the
starting point is an observation of an organism
showing an interesting biological activity. The cor-
relation between the chemical structures responsible
for the shown bioactivity needs to be studied to
understand the observation on a molecular level using
both in vivo, in vitro and in silico methods (Larsson
2007).
In the following sections, different parts of this
model are explained in more detail by description of
our research. Based on an observed ethnopharmaco-
logical use of plants against inﬂammation in depth
Fig. 1 Explanatory model the interdisciplinary nature of
pharmacognosy interpreted in an explanatory model presented
by Larsson and co-workers (2008). In this model a clearly
deﬁned role is presented for aspects of informatics, including
bio- and chemoinformatics. Figure by Sonny Larsson, copy-
right Phytochemistry Letters, reproduced with permission
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123studies of pure natural products against colon cancer
are now in focus. Ecological relationships among
organisms have resulted in studies of antifouling
properties of molecules isolated from marine sponges
and chemical proﬁling of fungi. Another project is
focused on bioengineering of circular proteins, so
called cyclotides, to create new structure–activity
relationships. Novel strategies are developed for
efﬁcient prediction and selection of organisms and
molecules and bioinformatic tools to predict novel
targets based on lateral gene transfer.
Natural products with anti-inﬂammatory
and anti-tumor activity
A scientiﬁc platform has been built in our long-term
research on anti-inﬂammatory natural products as
demonstrated in a number of publications and
doctoral theses. Our earlier research started with
ethnopharmacological observations and information
of the use of medicinal plants against different forms
of inﬂammation in different cultures. Many different
chemical structures have been discovered, and chem-
ically and pharmacologically characterised using
bioassay-guided isolation procedures. In vivo meth-
ods such as rat paw and mouse ear oedema was used
and later followed by in vitro enzyme and cell based
methods. Two systems have been established to
enable investigations of the effects of natural com-
pounds on COX-2. The ﬁrst method developed was
an in vitro method suitable for measuring inhibition
of COX-2 catalysed prostaglandin E2 biosynthesis,
based on scintillation proximity assay technology
(Huss et al. 2002). The second system comprises a
cell model, suitable for studying the effects of
compounds on COX-2 and inducible nitric oxide
synthase (iNOS) at different cellular levels, including
the effects on mRNA, protein, prostaglandin E2, and
nitric oxide levels (Huss 2003).
In later years the project has developed towards
enzyme inhibitors related to anti-tumor activity,
especially in colon cancer. It has been shown that
the process of inﬂammation and expression of
cyclooxygenase-2 is important in colon carcinogen-
esis. Another important factor is diet. Many food
phytochemicals have been shown to exert anti-
inﬂammatory activity in vitro, and may act as cancer
chemopreventive agents (Kim et al. 2003; Murakami
and Ohigashi 2007). A vegetarian diet rich in
phytochemicals may prevent colon carcinogenesis
by affecting biochemical processes in the colonic
mucosa. We have shown that intact faecal water
(water phase) samples from human volunteers sig-
niﬁcantly decreased prostaglandin production and
COX-2 expression in colonic cells. NMR spectros-
copy and multivariate data analysis were later used
for further analysis of the composition of the faecal
waters and to trace the COX-2 inhibiting activity
(Pettersson et al. 2008a, b). The wealth of different
natural products with experimentally demonstrated
COX inhibitory effects and an urge to understand and
characterize their structural diversity was the starting-
point for the application of chemography in our
natural products research.
The identiﬁcation from chemographic analyses of
some speciﬁc groups of compounds, including a set
of cardiac glycosides, as being of prime importance
was further established in a screening of a large
number of natural products for activity against
colorectal cancer where several cardiac glycosides
showed signiﬁcant activity. This activity was further
conﬁrmed in primary cells from colon cancer
patients. Cardiac glycosides have been reported to
exhibit cytotoxic activity against several different
cancer types, but studies against colorectal cancer are
lacking. Drugs for clinical treatment of colon cancer
are usually used in combination to overcome the
problem with drug resistance and to increase the
activity. Therefore, selected cardiac glycosides were
tested in combination with four clinically relevant
standard cytotoxic drugs (5-ﬂuorouracil, oxaliplatin,
cisplatin, irinotecan) to screen for synergistic effects.
The combination of digitoxin and oxaliplatin exhib-
ited synergism including the otherwise highly drug-
resistant HT29 cell line (Felth et al. 2009). In depth
studies are now in progress necessary to understand
these effects on a molecular level.
Marine organisms—substances with ecological
impact
The project is related to the sustainable use of natural
products and development of ‘‘green chemistry’’. The
future society needs biodegradable natural prod-
ucts with speciﬁc actions and low residence times,
e.g. for control of fouling organisms in the marine
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123environment. Marine organisms have shown to
contain a wealth of bioactive secondary metabolites
with potential for new pharmaceutical or biotechno-
logical applications. Marine sponges produce sub-
stances that have a key role in the defence against
pathogens, parasites, predators and biofouling
organisms.
In our earlier research we performed screening for
biological activity, using both in vivo and in vitro
methods, of marine organisms on the west coast of
Sweden. This work resulted in several publications
and two doctoral theses (Andersson 1987; Lidgren
1989). Extracts from the marine sponge Geodia
barretti, distributed in the Norwegian fjords and the
Swedish Kosterfjord, showed signiﬁcant biological
activity in several of the assays. These results
combined with the observation that Geodia barretti
possesses an almost completely fouling-free body
surface prompted a study of possible chemical
defense against and identiﬁcation of pharmacologi-
cally active molecules.
In this project we have isolated, characterized and
synthesized two cyclopeptides from the marine
sponge Geodia barretti, with effect on cyprid larvae
from Balanus improvisus that could explain why this
sponge is free from ongrowth of other organisms. The
objective of the studies was to further explore the
chemical diversity in Geodia barretti. Furthermore,
the aim was to understand the biological activity on
different targets and to evaluate if the compounds
produced by the sponge act in concert, either by
synergistic or cooperative action, and to investigate a
possible bacterial origin of the compounds.
For isolation of minor secondary metabolites state
of the art methods for chemical analysis have been
used, such as LC–MS, MS/MS and 2D-NMR. For
establishing biological activity a barnacle settlement
assay in vitro has been used to evaluate the effect of
the isolated compounds on the behaviour on cyprid
larvae. The brominated cyclopeptides have also been
tested further for afﬁnity to human serotonin recep-
tors using an in vitro radioligand-binding assay based
on displacement of radioligands from human 5HT-
receptors expressed in HEK-293 cell membranes. A
remotely operated vehicle has been used to evaluate
the release of secondary metabolites in ambient
water. Mass spectrometry has been used to under-
stand the interaction of the different metabolites and
dose–response calculations have been made to show
the synergistic activity, and different standard proto-
cols have been used to cultivate bacterial strains
associated with Geodia barretti (Sjo ¨gren 2006;
Fig. 2).
A novel dibrominated cyclopeptide, bromobenz-
isoxalone barettin, was isolated from Geodia barretti
using repeated extraction with acetonitrile and water,
desalted with RP-SPE and then fractionated using
RP-HPLC and detected with ESIMS. High resolution
MS and 2D-NMR were used for elucidation of the
chemical structure. The new compound displayed
settlement inhibition of barnacle larvae with an EC50
value of 15 nM (Hedner et al. 2008).
The brominated cyclodipeptides barettin and 8,9-
dihydrobarettin have previously been shown to inhibit
settlement of barnacle larvae in a dose-dependent
manner in concentrations ranging from 0.5 to 25 lM.
In order to further establish the molecular target and
mode of action of these compounds, we investigated
their afﬁnity to human serotonin receptors. The two
cyclopeptides selectively interacted with the serotonin
receptors 5-HT2A, 5-HT2C and 5-HT4 at concentra-
tions close to that of endogenous serotonin. Surpris-
ingly, the novel barettin analogue did not show any
effect on these receptors (Hedner et al. 2006; Hedner
2007). To gain further knowledge about the structure–
activity basis for the shown antifouling activity and
the effect on speciﬁc serotonin receptors, different
analogs, based on the chemical core structures of
Fig. 2 Geodia reef picture taken by remote operated vehicle at
120 m depth showing fouling-free marine sponges of the
species Geodia barretti and G. macandrevia living in the
Koster Fjord at the Swedish West-coast. Photo by Thomas
Lunda ¨lv, Tja ¨rno ¨ Marine Biology Laboratory, Sweden, used
with permission
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123combinations of barettin and dipodazin, were
designed and synthesised (Sjo ¨gren et al. 2006; Fig. 3).
We have recently shown that the two congeneric
defence cyclodipeptides, barettin and 8,9-dihydroba-
rettin, produced by the coldwater marine sponge
Geodia barretti act in synergy to deter larvae of
surface settlers. An in situ sampling using the
remotely operated vehicle at a depth of 123 m
revealed that the sponge continuously releases these
two compounds to the ambient water. We suggest
that the chemical defence in Geodia barretti involves
synergistic action, with congeneric compounds pro-
duced by the same enzymatic pathway, where one of
the targets is a 5-HT receptor and that the synergy of
barettin and 8,9-dihydrobarettin have developed to
reduce the cost for the sponge to uphold its chemical
defence.
In conclusion, our results emphasize that also
marine organisms in cold waters merits further
attention. The performed studies of the cold water
marine sponge Geodia barretti has not only given an
increased understanding of antifouling substances
and their interaction with cyprid larvae, but also
further knowledge about cold water marine sponges
and their possible role in the very old reef like
ﬁelds of sponges, which have been pointed out as
important hotspots of biodiversity in the North
Atlantic (Klittgaard 1995).
Biodiversity of fungi—combinatory strategies
of ecology and chemistry
Fungiareknownfortheir peculiarchemistry,differing
from that of both animals and higher plants. The
secondary metabolites of fungi are produced to aid
establishment in the various ecological niches of
different fungal life forms. Several of these metabo-
lites have played important roles as fungi-derived
drugs revolutionizing the treatment of several serious
conditions in man. Two such examples are penicillin
and cyclosporin. In the antibiotic peptide penicillin, a
b-lactam (4-membered cyclic amide) ring interferes
with the synthesis of the bacterial cell wall. Fungi
occasionally produce unusual amino acids and unlike
animals and higher plants, fungi may not only produce
and use the L- but the D-enantiomers in their biosyn-
thesisofsecondarymetabolitesresultinginanomalous
compounds. One example of this is the immunosup-
pressant agent cyclosporin, which is essential during
organ transplants to prevent rejection of the new organ
bytheimmunesystem.Cyclosporincontainsanumber
of unusual amino acids as well as both the L- and
D-enantiomers of alanine (Traber et al. 1989). We still
know relatively little about the general nature of
fungal chemistry and in addition to this we only seem
to know a fraction of the estimated number of existing
fungal species on Earth. Today approximately 14,000
Fig. 3 Structures
compilation of structures of
barettin (1), dipodazine (5)
and 13 analogues
synthesized and tested by
Sjo ¨gren and co-workers
(2006)
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123species of macrofungi are known to science, but
estimations show that this may well be only a tenth of
the actual number of all living macromycete species
(Hawksworth 2001). For fungi in the widest sense, the
total number of species on Earth has been estimated to
1.1 million (Mueller et al. 2007). Within the fungal
kingdom lies a vast, and to a large extent, still
unexplored potential for future pharmaceutical drugs.
In the section Fungi in Linnaeus’ Materia Medica
(1749), the genus Lycoperdon is mentioned as an
aphrodisiac and remedy against ﬂatulence. Most
probably this passage refers to what today is known
as the deer trufﬂe, Elaphomyces granulatus, earlier
known under the name Boletus cervini. In more
recent sources the deer trufﬂe has been reputed for its
abilities to induce oestrus manifestation in cows
(Klintberg 1998), forming a somewhat unsuspected
link to the Linnaean indication. The edible trufﬂes of
the genus Tuber have historically been used as an
aphrodisiac by both men and women and in modern
science small amounts of the steroid androstenol has
been found in mature specimens of the black trufﬂe
Tuber melanosporum. Androstenol is a major com-
ponent of the boar pheromone, excreted in the saliva
during mating (Claus et al. 1981).
Trufﬂes are an intricate fungal life form occurring
in both the two major groups of macromycetes: asco-
and basidiomycetes (see Fig. 4). Only within the
ascomycetes, species that develop trufﬂe fruit bodies
are estimated to have evolved at least ﬁfteen times in
multiple families (Læssøe and Hansen 2007). Thus,
from a modern phylogenetic perspective, trufﬂes are
regarded as a life form rather than a speciﬁc group of
fungi. Despite this, all trufﬂe species, regardless of
phylogenetic placement, live in mycorrhizal symbio-
sis with vascular plants. Due to their hypogeous nature
and subsequent loss of active spore dispersal, all
trufﬂe species are also dependant on an animal vector
for spore dispersal. The evolution of a hypogeous fruit
body might be an adaptation to dry climatic condi-
tions, but the relationship between the hypogeous
fungus, the tree and the animal vector seem to be
imperative for the life and distribution of this life form
suggesting a more sophisticated fungal niche against
vertebrates. The dispersal vectors may be mice,
squirrels, deer or wild boars (Trappe and Castellano
1991). Consequently the trufﬂes, i.e. the hypogeous
spore-producing fruiting bodies, have developed a
diverse set of volatile substances to attract these
vectors, and to make them unearth and eat the trufﬂes,
thereby spreading the spores. Depending on the
animal vector’s lifestyle and ecology, these spores
may be deposited in the shape of fecal pellets close to
the roots of mycorrhizal trees (Trappe and Castellano
1991). Trufﬂes also show high levels of endemism
(Mueller et al. 2007), which may be explained by
mammalian fecal pellets being their main mean of
spore dispersal (Fig. 5).
Fig. 4 Phylogeny of fungi phylogeny of asco- and basidiomy-
cetes with focus on taxa with hypogeous fruiting bodies,
trufﬂes, based on a combination of several published studies
(Læssøe and Hansen 2007; Hibbet et al. 2007; Celio et al.
2006). Taxa labeled in blue with • indicate evolutionary groups
that have developed trufﬂes. The most well known trufﬂe-
producing family, Tuberaceae, comprising the edible white and
Burgundy trufﬂes is further emphasized in bold lettering.
Figure by Christina Wede ´n and Anders Backlund
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provides a good model, with a narrow genetic
variation (Wede ´n et al. 2005), enabling method
development and an understanding of the type and
range of intraspeciﬁc variation in secondary chemis-
try. On the Swedish island of Gotland, the population
of T. aestivum poses several interesting challenges.
After the last glaciation, the highest parts of the
island of Gotland reappeared as an island above what
was then a fresh water lake approximately 11,600
years ago. The European hazel, Corylus avellana was
the ﬁrst possible Tuber aestivum host tree to become
establish on Gotland some 9,000 years ago (Pa ˚hlsson
1977). This detailed and well studied history of
Gotland’s quartenary geology provides us with
unique parameters for the calculation of the date
for, and rate of, genetic divergence of Tuber
aestivum, as well as possible island biogeographic
hypotheses for the mode of introduction. Population
dynamics and dispersal patterns on newly introduced
land and over large bodies of water might also be
tested.
By analysing secondary chemistry in combination
with DNA sequence data we aim to ﬁnd possible
variation and congruencies within trufﬂe populations.
Tuber aestivum on the island of Gotland has been
found to consist of a closely related population
possibly indicating a single introduction or several
introductions from a similar source (Wede ´n et al.
2004). Genotypes showed a normal distribution
indicating sexual reproduction (Wede ´n 2004).
Despite the genetic homogeneity, local trufﬂe hunters
have reported differences in the organoleptic proper-
ties of trufﬂe fruit bodies between different sites. In
an ongoing study of the Gotland T. aestivum popu-
lation, we have aimed to investigate if chemical
differences could be site speciﬁc or correlated to
genetic traits. The molecular data set consists of
sequences of the internal transcribed spacer region
(ITS) from fresh fruit bodies of T. aestivum from
15 different localities on Gotland. Ethanol extracts of
the same fruit bodies have then been analysed with
LC–MS to create a data set of chemical proﬁles
corresponding to that described by Ekena ¨s and
co-authors (2009).
It is noteworthy that the volatile substances attract-
ingthedispersalvectors areonlyproducedwhenspore
maturity in the trufﬂe has reached 100% (Wede ´n
2004), thereby preventing premature dispersal. For
some trufﬂe species, this signalling mechanism acting
as an olifactory triggering stimuli in vertebrates in
nature, also appeals to the human pallet. A few trufﬂe
species are appreciated as delicacies, due to their
appealing, intense and complex aroma. Volatile and
non-volatilecomponentsoftrufﬂesarebeingstudiedto
understand the nature of these interactions (Fig. 5).
Bioengineering—chemical structure
and biological activity of cyclotides
Plant peptides and proteins may be considered an
overlooked source for new chemical entities and
novel bioactivites compared to low molecular natural
products. The reason for this seems to be based on
tradition and biased by the most commonly used
techniques for natural products research. For exam-
ple, most researchers in the ﬁeld tend to avoid water
Fig. 5 Section of trufﬂe the characteristic scent of the
Burgundy trufﬂe does not develop until the entire spore mass
has matured, indicating a sophisticated chemical control
mechanism. In the picture above we see a fruit body of the
trufﬂe Tuber aestivum from the island of Gotland with
completely matured spores, showing the interior with a
characteristic marbled brown gleba. Photo by Erika Lide ´n
 2009, used with permission
Phytochem Rev (2010) 9:279–301 287
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ination of peptides and proteins already at an initial
stage. However, during the last decades, the number
of reported plant peptides has grown substantially,
and the ﬁeld is about to mushroom. In our laboratory,
plant peptides was a topic of research already in the
1950s through to the early 1980s, in the form of
Professor Gunnar Samuelssons’ pioneering studies of
mistletoe toxins (Samuelsson 1958). In the mid 1990s
we made an attempt to assess plant peptides more
broadly, with the design of an isolation protocol
directly designed for their isolation (Claeson et al.
1998). One of the results of this effort was the
discovery of a set of macrocyclic peptides in the plant
family Violaceae (Go ¨ransson et al. 1999).
Strikingly, the peptides we characterised in Viol-
aceae were found to be nearly identical with one of
the most intriguing examples of pharmacognostic
research in general, and plant peptides in particular,
namely the peptide Kalata B1. The discovery of
Kalata B1 was based on the ethnopharmacological
use of the plant Oldenlandia afﬁnis. During a Red
Cross mission in Congo, the Norwegian physician
Lorents Gran experienced a high frequency of
complicated deliveries due to the use of this plant,
which was locally known as ‘‘Kalata-Kalata’’ (Gran
1973a, b). Native women secretly used a decoction of
this plant to facilitate childbirth, which they sipped as
a tea but also applied directly at the birth canal (Gran
et al. 2000). It induced extremely strong uterine
contractions, which sometimes developed into cervi-
cal spasms necessitating acute caesarean section. On
a second session in the same area some years later,
the identity of the plant was revealed to Gran, who,
triggered by his observations, brought the plant back
to Norway for biological and chemical characterisa-
tion. He found that a peptide, Kalata B1, was the
active component. The complete sequence and the
cyclic structure was however not determined for more
than 20 years later (Saether et al. 1995).
At the time of our report of the ﬁrst cocktail of
‘‘kalata-like’’ peptides in Violaceae, four similar
peptides had been reported in the literature as the
serendipitous discoveries of three independent
groups. When including those peptides in a sequence
comparison, i.e. the anti-HIV circulins A and B, the
neurotensin binding inhibitor cyclopsychotride A and
the partially characterised violapeptide I, it was clear
that they fell in two subgroups based on sequence
similarity. This was conﬁrmed by the landmark study
by David Craik and coworkers that introduced the
name cyclotides (as an acronym for cyclic peptides),
and the two subfamilies were termed Mo ¨bius and
bracelet cyclotides, based on the presence and
absence, respectively, of a cis-proline bond.
Today, around 150 cyclotides have been reported
from species of three plant families, Violaceae,
Rubiaceae and Cucurbitaceae. The family Violaceae
seems to be particularly rich in these proteins
(Go ¨ransson et al. 2003, 2004b; Herrmann et al.
2008; Ireland et al. 2006; Simonsen et al. 2005), and a
single Violaceae species may contain more than 60
different cyclotides. It has been suggested that there
might be [9,000 cyclotides in the Violaceae alone
(Simonsen et al. 2005).
The structure of a representative cyclotide, varv F
(Wangetal.2009),isshowninFig. 6.Inadditiontothe
amide bond that cyclise the backbone, cyclotides
contain three stabilising disulﬁde bonds in a knotted
arrangement, i.e. two disulﬁdes form a ring together
with their connecting protein backbone, which is
threaded by the third disulﬁde (Go ¨ransson and Craik
2003; Rosengren et al. 2003; Saether et al. 1995).
Together these features deﬁne the cyclic cystine knot
Fig. 6 Cyclotide structure. The ﬁgure shows a ribbon
representation of the crystal structure of varv peptide F
(pdbcode 3E4H). Note the seamless peptide backbone and
the three disulﬁdes bonds (in yellow) that form the cystine
knot: CysI–CysIV, II–V, III–VI. The six loops are marked with
roman numerals. Figure by Ulf Go ¨ransson
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protein structures (Colgrave and Craik 2004). In fact,
they are impervious to enzymes, and, as indicated by
the native’s use of decoction as an extraction method,
cyclotides also withstand boiling water.
The sequences between the cysteines, referred to
as loops, are more or less variable. Notably, the loops
confer additional characteristics that differentiate the
typical Mo ¨bius and bracelet cyclotides; in particular
the bracelet cyclotide contain a longer loop 5 that
forms a short a-helix and a cluster of cationic
residues in loop 3. As the cyclotide family grows
however, more and more peptides are discovered that
contain features from both subfamilies, so called
hybrids. In addition, the peptides from the Cucurbit-
aceae plant family form a third subfamily that
basically only has the CCK motif in common with
Violaceae and Rubiaceae cyclotides. The meagre
sequence similarity might indicate that these peptides
evolved convergently to Mo ¨bius and bracelet cyclo-
tides (instead they show homology to the linear
trypsin inhibitory peptides from Cucurbitaceae).
As mentioned above, the early cyclotide discover-
ies were due to their biological effects. Although not
all of the around 150 cyclotides that we know today
have been tested in any assay, the number and types of
biological effects are impressive. Besides being uter-
otonic, anti-HIV, haemolytic and neurotensin binding
inhibitory, the list now includes antimicrobial (Tam
et al. 1999), antifouling (Go ¨ransson et al. 2004a),
antihelmintic (Colgrave et al. 2009), molluscicidal
(Plan et al. 2008), cytotoxic (Lindholm et al. 2002;
Svanga ˚rd et al. 2004) and insecticidal (Jennings et al.
2001)activities.Thelattereffectsaresomeofthemost
well studied and interesting effects: the cytotoxic
effect together with the haemolytic effect have been
the focus for detailed structure activity studies
(Go ¨ransson et al. 2009; Herrmann et al. 2006), and
the discovery of their insecticidal effect likely
revealed cyclotides’ role in planta. Cyclotides’ mech-
anism of action is however yet unknown, but evidence
is accumulating showing that membrane interactions
followed by membrane pore or ﬁssure formation are
involved (Kamimori et al. 2005; Shenkarev et al.
2006; Svanga ˚rd et al. 2007), which could provide an
explanation to several of the reported effects.
Combined with the extraordinary CCK motif—
with its conserved scaffold that can be dressed with
variable loop sequences—the demonstrated biological
activity of the cyclotides make them a ﬁrst class target
for protein engineering. To this end, inherent activites
of native cyclotides can be reinforced or abolished, or
new biologically active peptide epitopes can be
grafted into the scaffold. For example, reinforcing
the cytotoxic effect could potentially provide us with
leads for anticancer drugs, or to completely remove
that effect could provide us with an inert scaffold ideal
for grafting. The ﬁrst successful grafting of a biolog-
ically active epitope was reported just recently,
showing proof of concept (Gunasekera et al. 2008).
The success of these strategies relies on the
ability of efﬁcient methods for production of
cyclotides and cyclotide mutants. Being gene prod-
ucts, cell based production systems seem promising,
but although cyclotide producing plant cell cultures
have been established (Seydel and Do ¨rnenburg
2006), solid phase peptide synthesis is still the
method of choice (Gunasekera et al. 2006; Leta
Aboye et al. 2008).
Our knowledge about their biosynthesis is yet
scarce. We know the structural arrangement of the
cyclotide precursor from cDNA, and that an asparag-
inyl endopeptidase has a likely role for cleaving at the
N terminal side of the mature peptide and that protein
disulﬁde isomerases seem to play a role for their
successful folding. However, the order of the events to
produce mature cyclotides is not yet known, i.e. if
disulﬁde bonds are formed before or after excision and
ligation, and nothing is known about how these
processes are controlled. In the perspective of exploit-
ing the cyclotide scaffold for engineering of bioactive
peptides, the possibility of farming designed mole-
cules in planta promises to be the optimal solution; the
way there is still long though.
Strategies of selection—using phylogeny
and chemography
More than two centuries ago in his Clavis Medicinæ
Duplex Linnaeus wrote:
Plants which correspond to genus correspond
also in their properties. Plants that stand close in
their natural order also stand close to each other
with regards to their virtues.
Linnaeus, 1766
[authors’ translation from latin]
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of evolution, Linnaeus formulates this stipulate based
on his general knowledge on plants and their
application as drugs. This insight was revived and
reformulated a century later by Helen Abbott, who
concluded that:
The evolution of chemical constituents follows
parallel lines with the evolutionary course of
plant forms, the one being intimately connected
with the other…
Helen Cecilia De Silver Abbot, 1887
Franklin Institute lecture:
The chemical basis of plant forms
Extrapolating from these clear-sighted suggestions
one arrives at the thought that there ought to be a
pattern of correlation between implications derived
from exploration of chemical constituents, and those
from evolutionary studies. Starting with the initial
attempts to characterize chemical properties, such as
in the thesis by Hiortzberg (1765)—one of the ﬁrst in
medicinal chemistry at Uppsala University—to pres-
ent day exploration and charting of chemical space,
and in analogy from the Linnaeus classiﬁcations of
the eighteenth century to modern phylogenetic stud-
ies of evolutionary space.
The concept of chemical space is an attempt to
transform physical–chemical data to the correspond-
ing information. One way to pursue this task is
explored in the area of chemography, where analo-
gies are drawn to geography. As in geography the
primary task in chemography is to produce a map to
serve as a basis for exploration. Given that chemical
space includes all known, and in principle also all
possible compounds the sheer size gets woeful. It has
been estimated that there are well above 10
60 possible
small carbon based compounds (Bohacek et al. 1996)
and including also small peptides the number of
compounds quickly rise to at least 10
390 (Dobson
2004). But to further complicate the endeavour
chemical space is, as Shoichet puts it: ‘‘…vast but
most of it is biologically uninteresting; blank, light-
less galaxies exist within it into which good ideas at
their peril wander’’ (Shoichet 2004).
With this bleak perspective, it is comprehendible
that a considerable effort has been invested in
predicting and deﬁning the sectors or multi-dimen-
sional volumes having the best chance of containing
the sought-for properties or molecules (Kirkpatrick
and Ellis 2004). In pharmacognosy, as in many
related ﬁelds of research such as chemical ecology,
chemical biology and medicinal chemistry, the focus
has been directed to sectors believed to contain
molecules with biological activities. These are usu-
ally referred to as the ‘‘biologically relevant chemical
space’’, and the limits of this multidimensional
subvolume are deﬁned by properties and boundaries
which allow for binding interactions between biolog-
ical molecules, such as primary and secondary
metabolites, polypeptides, enzymes, RNA, and
DNA (Lipinski and Hopkins 2004). In populating
the biologically relevant chemical space with mole-
cules, evolutionary forces have led to the creation of
an array of inspiring and unique structures—often
combining properties that are difﬁcult to access by
synthetic chemistry (e.g. Hall et al. 2001; Kingston
and Newman 2002; Booth and Zemmel 2004;
Rawlins 2004; DiMasi et al. 2003; Pucheault 2008).
To facilitate this exploration, a global map of
natural products chemical property has been devel-
oped following the principles for the Earth global
positioning system (GPS). Starting with 1779 ‘satel-
lite’ and ‘core’ compounds evaluated with 35 care-
fully selected chemical descriptors, and validated
using more than 1.2 million compounds of natural
and non-natural origin resulted in ChemGPS-NP. The
development of this prediction model, as well as the
public web-interface ChemGPS-NPweb available at
http://chemgps.bmc.uu.se have been described in
previous studies (Larsson et al. 2005, 2007; Rose ´n
et al. 2009b). Starting with a chemical structure,
related information can be retrieved in massive
amounts by simple procedures, typically from a
software package. Such computed information forms
the raw material for a majority of the charting
endeavours published (e.g. Kirkpatrick and Ellis
2004; Oprea 2002; Agraﬁotis et al. 2002; Oprea and
Gottfries 2001; Haggarty et al. 2004).
A central dogma of medicinal chemistry and
chemical biology is that compounds with similar
structures have similar activities. Although there are
also numerous examples to the contrary (Kubinyi
1998; Martin et al. 2002) this appears in most cases to
be true, and it is reassuring when different methods of
exploration such as ethno-pharmacology, database
exploitation, and molecular modelling converge on a
common suggested lead compound (Bernard et al.
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and estimating chemical diversity, have been pursued
by the pharmaceutical industry. The initial driving
forces were to be able to predict (Carhart et al. 1985)
or expand (Willett et al. 1986) results from ongoing
studies by comparing chemical similarity of com-
pounds (Willett et al. 1998; Holliday et al. 2003).
However, with the advent of large screening libraries
and increasingly more complex targets, the need for
stringent selection and experimental design to deter-
mine the diversity of a set of compounds became
more important (Drie and Lajiness 1998).
In most studies on chemical diversity only the
‘‘chemical space of small molecules’’ or CSSM
(Pollock et al. 2008) have been included, excluding
more complex molecules such as polypeptides and
enzymes which in our opinion ought to be included in
the concept of chemical space (Walsh 2001). This
poses important questions on data handling and
descriptor selection, as there are inherent differences
between these groups. While members of CSSM are
biosynthesized via biosynthetic pathways, usually
from a limited set of building blocks and in a chiral
speciﬁc manner the polypeptides are in most, and
enzymes in all, cases ribosomal products encoded by
genes. This brings them closer to the evolutionary
forces, as these processes act directly on the (genes
coding for the) molecules, and their immediate
expression (Kapralov and Filatov 2007; Andersson
and Backlund 2008). On the other hand in the case of
CSSM, the evolutionary forces act on the biosyn-
thetic machinery, which may still after substantial
modiﬁcations be able to perform the same synthesis
resulting in a product indistinguishable from that of
an unmodiﬁed enzyme. These differences have been
explored by Larsson in a thesis on the toxic
polypeptides of mistletoes (Larsson 2007).
What may then be the biological relevance of these
chemical substances and their traits? In Nature
virtually all (if not all) processes noticeable within
and between organisms and their environment are
fundamentally chemical reactions. These reactions
are to an extensive degree mediated via elaborate
enzymes, complex proteins and various high- and low
molecular weight compounds, all of which are
themselves synthesized ‘on purpose’. Even if we at
present only understand a minute fraction of these
interactions, we can be conﬁdent about the fact that
they have been and continuously are evaluated and
validated by evolutionary processes. They are all
there for a reason—obvious or not.
One application of ChemGPS-NP and its charting
potential is demonstrated in the following example. A
set of more than 49,554 molecules (Fig. 7a) has been
screened for activity in a pyruvate kinase assay, with
no more than 587 actives retrieved. Wondering to
Fig. 7 Comparison of chemical space plots (three subﬁgures)
comparing chemical space coverage from three datasets,
a 49,554 compounds screened in the pyruvate kinase assay
[grey], b 20,434 compounds from the ZINC-NP subset
[magenta], and c 178,210 compounds from WOMBAT
2007.1 corresponding to substances with demonstrated biolog-
ical activity [lime]. Red axis = PC1, corresponding to size
parameters, yellow axis = PC2, corresponding to aromaticity
and conjugation related parameters, and green axis = PC3,
corresponding mainly to lipophilicity. Figure by Anders
Backlund, all predictions scores calculated using ChemGPS-
NPweb, plotted using Apple MacOS X bundled software
Grapher 2.1
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sampled the physical–chemical properties of the
tested molecules can easily become charted together
with appropriate datasets for comparison. Introducing
a sub-sample of 20,434 molecules from the ZINC
database, labelled as ZINC-NP (Fig. 7b), as well as
178,210 compounds from the WOMBAT database
(courtesy of Sunset Molecular) (Fig. 7c) we imme-
diately make two conclusions. Firstly, that the tested
sample only corresponds to a limited part of the
experimentally determined and known biologically
relevant chemical space. Secondly, that even the
ZINC-NP subset of circa half the number of
compounds, as compared to the test set, covers a
signiﬁcantly more diverse volume of chemical space.
It is obvious, however, from Fig. 7c that the ZINC-
NP set (pink) is comparably well represented among
the low molecular compounds, while WOMBAT
(lime) covers a much wider range among the larger
molecules.
While there is a general agreement on the concept
of chemical space, opinions are much more diverse
when it comes to biological space. Some authors see
biological space as a subset of chemical space
including the chemistry that is related to life, while
others envisage a much broader view and even in
some cases promote the opposite view—that chem-
ical space is a subset of the biological space.
Regardless of which, it is obvious that there is a
tight link between parts of these two entities at least.
As is the case also for the chemical space, exploration
of the biological space can be done at different scale.
Detailed knowledge on enzymes, structures, binding
afﬁnities and functions (Bologa et al. 2006; Blundell
2007), the patterns of change in proteins during
evolution (Andersson and Backlund 2008; Taylor
et al. 2001), or the over all patterns of change,
speciation, and extinction that are the combined
results of evolutionary forces (Angiosperm Phylog-
eny Group 1998, 2003), all form small contributions
to an understanding. In this explorative process the
concept of biological diversity has become central. In
measuring and quantifying the elusive property
‘‘biological diversity’’, the advances in phylogenetic
reconstruction have become instrumental. With the
initial premise set in the beginning of this section,
that there are connections between evolution and
chemistry, it can be inferred that a larger evolutionary
or biological diversity should also indicate a
potentially larger chemical diversity. This is one
reason why the marine environment has attracted
recent attention by natural product chemists in search
for novel chemical entities (Hall et al. 2001; Lei and
Zhou 2002; Newman and Hill 2006).
A phylogenetic hypothesis, in short a phylogeny, is
an implicit hypothesis of evolutionary relationships.
Such hypotheses can be erected based on intuition, as
for example by Haeckel (1866), but are in a modern
systematic or evolutionary biology context a result of
careful analysis of scientiﬁc data. From a philosoph-
ical standpoint there is only one evolutionary history,
and evolution hence ought to be represented as one
single, bifurcating, tree diagram showing the evolu-
tion and succession of all species. The crux being to
ﬁgure out which of the different possible trees that is
‘correct’, i.e. in the best way representing the result of
the evolutionary processes. This is not a trivial
problem, and to further complicate the situation, it is
today widely accepted that only a bifurcating tree is
not adequate for this purpose. This considering the
known and well-studied processes of hybridization
and lateral gene transfer—the latter explored in great
detail for example through the research by Alsmark
described in the following section dealing with target
identiﬁcation.
An immediate consequence of the relentless
activities by evolutionary forces is that the biological
space is at a constant state of change. This is also
different to the chemical space where each substance
as such (known or hypothesized) has its ﬁnite
position, although different depending on the refer-
ence system applied. Evolution as such does not give
room for nostalgia and retaining unnecessary and
unimportant features. Everything in Nature is there
and kept for a purpose—even if that purpose at
present may be difﬁcult for us to un-earthen. One
such example can be seen in the enzyme ribulose-
1,5-bisphoshate carboxylase/oxygenase, or rubisco,
in which the history, development, and ﬁne-tuning
can be followed from possible Archaean enolizing
enzymes via large subunit dimers in photosynthesiz-
ing purple and alpha bacteria to the ‘modern’
hexadecamer with both large and small subunits
(Andersson and Backlund 2008). From this study, as
well as previous work, features such as positive
selection (Lodish et al. 1999), importance of the
genetic code redundancy and rate changing separa-
tion of gene operons can be illuminated.
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organisms and their chemistry is a result of their
common history (Linnaeus 1766; Abbott 1887).
Forming two sides of a coin, each will tell us
something about the other. Presence of a unique
compound would be an argument for a common
ancestry or a result of sharing a common endogenous
parasite or symbiont (el-Seedi et al. 2005). In the
same way would close evolutionary kinship increase
the chance of encountering similar chemistry (Backl-
und and Moritz 1998). The tools for biosynthesis are
not only modular, ﬂexible and adjustable, they are
also at a normal state strongly regulated and perform
their tasks following a complex array of control and
feedback loops. Attempting to step out of our
anthropocentric view this appears quite logical and
consequently. Dobson (2004) conclude that one of
the greatest challenges for the future of biosynthesis
research is to understand how these systems could be
inﬂuenced to perform in ways better suited for our
needs for e.g. production of better drugs, food or
building materials.
There is, as mentioned above, a fundamental
difference between the chemical space and the
evolutionary space. In the latter the single and same
result is the expected outcome of different
approaches to interpret evolution—as there is sup-
posedly one single (albeit in some cases entangled
and reticulate) evolutionary history for organisms on
Earth. Chemical space, however, is characterized by
an array of more or less well-suited molecular
descriptors. When selecting a set of descriptors, this
will inﬂuence the way in which the corresponding
chemical space can be demonstrated. Hence, the
process of selecting descriptors becomes central in
chemical space exploration to a much greater and
more direct extent that the selection of a particular
method for phylogenetic analysis. The same comes
true for selection of exemplar compounds or training
set of compounds, as compared to which organisms
are included in a phylogenetic study.
Even if many natural products display a wide
range of biological activities, they are not honed by
evolutionary forces with the purpose of becoming
drugs for use in humans. What they may contribute
with, however, is an amazing chemical diversity
(Kingston and Newman 2002). This becomes very
clear in cases such as the natural product cycloox-
ygenase (COX) inhibitors. The COX enzyme system
of the inﬂammation cascade appears in at least two
isoforms, COX 1 and COX 2, of which the latter is
induced and involved in for example the complex of
chronic inﬂammation. Compiling data on more than
200 published COX-1 and 2 inhibitors of natural
origin, their mode of inhibition, and their organism
of origin provide us with an intriguing pattern—
both chemographic and phylogenetic—displayed in
Fig. 8.
The biologically relevant parts of chemical space
could be deﬁned as those in which we ﬁnd natural
products, as there is a general belief that evolutionary
pressure would, with time, prohibit biosynthesis of
compounds, which are not contributing to organism
ﬁtness. On the other hand, biologically relevant
chemical space could be deﬁned as those parts of
Fig. 8 Chemical space plot of COX inhibitors chemical
property space plot of 242 natural products with experimen-
tally demonstrated COX-inhibitory effects. Red axis = PC1,
corresponding to size parameters, yellow axis = PC2, corre-
sponding to aromaticity and conjugation related parameters,
and pink axis = PC8, corresponding primarily to the Lipinski
alert index (LAI), positive values indicating Lipinski ‘rule of
ﬁve’ violation. Note signiﬁcant variation in size, and large
proportion of compounds with positive LAI values. Picture by
Anders Backlund, all predictions scores calculated using
ChemGPS-NPweb, plotted using Apple MacOS X bundled
software Grapher 2.1, data compiled by Maria Schro ¨der-Vilar
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123chemical space in which substances with demon-
strated biological activities are encountered. The
latter deﬁnition would then include not only natural
products but also semi-synthesized or completely
synthetic drugs, hit substances from biological assays
etc., and hence is different from the ﬁrst. In an
attempt to characterize the overlap or difference
between these two different views of biologically
relevant space, an experiment was designed by Rose ´n
et al. (2009a). In this experiment more than 186,000
compounds from the database Wombat 2007.1
(‘World of Molecular Bio-Activity’), and 160,000
substances from ‘the Dictionary of Natural Products’
were extracted as SMILES. Both of these sets were
subsequently predicted in the ChemGPS-NP chemical
property space. The different distributions of the two
datasets are very obvious, with features such as a large
number of rigid compounds with a low proportion of
aromaticity in the Wombat dataset, but not yet tested
in biological assays. This ﬁts well with what could be
expected from the general section on differences
between natural products and products from chemical
synthesis, a cadre to which a comparably large portion
of the compounds with experimentally investigated
biological activity belong. In addition to these more
general conclusions, the development and application
of a novel similarity measure based on Euclidean
distance in chemical property space is described. This
approach is fundamentally different compared to
structure based similarity measures such as the
Tanimoto-index. Using the Euclidean distance mea-
sure, the closest neighbours to a set of well-known
drugs can be retrieved and investigated from the
available wealth of natural products.
Prediction of targets using bioinformatic
tools—lateral gene transfer
Over the past few years it has become apparent that
lateral gene transfer (LGT) has played an important
role in the evolution of pathogenic prokaryotes. LGT
is the transfer of genetic material between distinct
evolutionary lineages. This contrasts with what is
considered to be the ‘normal’ process of inheritance,
id est the transmission of mutations and traits from
parents to offspring, also known as vertical inheri-
tance. While point mutations are quantitatively the
major mode of evolution they generally exert their
effects slowly. In contrast, LGT offers the opportu-
nity of evolution by acquisition whereby radically
new capabilities such as the ability to utilize new
metabolites or the acquisition of drug resistance
genes may be acquired quickly. While it is widely
held that LGT has exerted a major quantitative and
qualitative effect on prokaryotic genomes (Ochman
et al. 2000), the role played by LGT—outside the
major endosymbiosis events—in the evolution of
eukaryotes, including pathogens and parasites of
humans and their livestock, is still poorly understood
(Doolittle et al. 2003). The main obstacles in analyses
have been the reliable inference of LGT on a genomic
scale as well as the functional assignment of genes in
often very poorly studied organisms. Recent reports
about failed treatment due to emerging resistant
strains, highlights the urgent need for new drug
targets.
In collaboration with TIGR (the Institute for
Genomic Research) and the Sanger Institute we have
made genome wide tree based screens for LGT in the
genomes of Entamoeba histolytica (Loftus et al.
2005; Clark et al. 2007), the trypanosomatides
(Berriman et al. 2005; El Sayed et al. 2005) and
Trichomonas vaginalis (Carlton et al. 2007). These
organisms are increasingly-difﬁcult-to-treat parasites
affecting millions of people and animals in the
developed and developing world every year. The
need for new drugs to treat infections by eukaryotic
parasites is becoming increasingly evident as new
reports of resistant strains continually emerge. At
present metronidazole is the drug of choice used to
treat Entamoeba histolytica, Giardia lamblia and
Trichomonas vaginalis. However, it has numerous
side effects such as nausea, vomiting, diarrhea,
hypersensitivity and encephalopathy (Cudmore
et al. 2004). Metronidazole has also been reported
to be carcinogenic in rodents (Bendesky et al. 2002)
and is known to pass the placental barrier in humans.
In addition, strains resistant to metronidazole are
being increasingly reported. The need for new drugs
is therefore urgent.
Because these pathogens are also eukaryotes, they
have only a few clear-cut metabolic and genetic
differences to mammals. LGTs are attractive candi-
dates for drug targets since their prokaryotic origin
make them less likely to have a vulnerable homolog
in mammalian genomes and hence the drugs may
have less side effects on patients. Our previous
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differences between the parasites and their hosts are
due to LGT into the parasite genomes. Many of the
LGTs detected lack a homologue in mammalian
genomes, for example 5-amino-6-(5-phosphoribo-
sylamino) uracil reductase, is active in riboﬂavin
metabolism in Trichomonas vaginalis, but not in
humans. Other LGTs, inferred by phylogeny as
bacterial like, are likely to be structurally different
to the ancestral eukarytotic homologue, for example
D-hydantoinase in Entamoeba histolytica. Better
understanding of the metabolic impact of LGT in
eukaryotes will guide us in the screen for potential
drug targets.
A variety of methods, each with its strengths and
weaknesses have been developed to infer the occur-
rence of LGT (Ragan 2001). Detailed phylogenetic
analysis, using sophisticated models of sequence
evolution, to detect topological incongruence with
established relationships is considered to be the ‘gold
standard’, but is too time consuming to apply directly
to entire genomes. We have combined rapid screen-
ing methods for LGT followed by more detailed
phylogenetic analysis of genes that pass the primary
screen. The starting point is a Python programme for
automated genome analysis called sPyPhy (Sicheritz-
Ponte ´n and Andersson 2001). The software sPyPhy
automatically generates protein distance phylogenetic
trees for all genes in a genome. All information
generated, such as BLASTp hits, ClustalW align-
ments, database information and the bootstrap con-
sensus trees are available for manual inspection
through a user-friendly matrix of clickable gene
entries. The matrix can be searched in a ﬂexible way
so that the best candidates for LGT can be selected.
The second stage of the analysis for LGT involves
piping alignments selected from the primary screen
described above into the programme MrBayes (Huel-
senbeck and Ronquist 2001). MrBayes carries out
Bayesian phylogenetic analysis (Rannala and Yang
1996) of proteins using a range of sophisticated
evolutionary models; the parameters of which can be
estimated from the data during the analysis. Pub-
lished simulations and empirical studies strongly
suggest that these more sophisticated models produce
more reliable trees, particularly for more divergent
sequences like those found in parasites (Hirt et al.
1999). Each candidate LGT is analyzed by MrBayes
using the WAG matrix (Whelan and Goldman 2001),
a gamma correction for site rate variation and a
proportion (pinvar) of invariable sites (Yang 1996).
MrBayes uses the likelihood function and the
Metropolis-coupled Markov Chain Monte Carlo
method to sample model-parameter and tree space
(including branch length), producing a set of trees
and model parameter values from which a consensus
tree is made. Because posterior probabilities, the
support values used by Bayesian analysis to indicate
conﬁdence in groups, have been criticized (Cum-
mings et al. 2003) we will also use bootstrapping to
provide an additional indication of support for
relationships. All cases where the tree topology
shows one of our chosen parasites clustered with
prokaryote sequences separated from any other
eukaryote by at least one well supported (bootstrap
0.7, posterior probabilities 95) node was considered
as a LGT in that species.
In Entamoeba histolytica a total of 5,740 trees
were made and 548 of these were selected from the
primary screen as representing potential LGT. The
548 candidate genes were then processed through the
secondary screen to make better trees with a Bayesian
approach. From the 548 trees LGT could be unam-
biguously inferred in 68 cases. The remaining 452
cases remained unresolved, but do not show vertical
inheritance. Similar results were achieved from the
trypanosomatides and Trichomonas vaginalis. These
analyses are preliminary but a number of points can
already be made. The ﬁrst is that LGT into these
protozoa genomes from bacteria does seem to have
occurred, and potentially to a signiﬁcant degree. The
putative LGTs in Entamoeba histolytica are inte-
grated into diverse metabolic pathways, including
amino acid, nucleotide and amino acid metabolism
(see Fig. 9).
In Trichomonas, metabolic pathways affected
include salvage pathways, amino acid metabolism,
synthesis of lipophosphoglycan and many more (as
indicated in Fig. 10).
Thus, in the broadest sense LGT must be affecting
the ﬁtness of the recipient organism. For Entamoeba
histolytica, 45% of the inferred transferred genes are
hypothetical or unclassiﬁed proteins and in Tricho-
monas vaginalis the corresponding value is 33%.
These values may simply reﬂect the observation that
for Entamoeba histolytica and Trichomonas vaginalis
around30%of the proteinspredicted fromthe genome
sequence are also hypothetical or unclassiﬁed. The
Phytochem Rev (2010) 9:279–301 295
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Entamoeba may be directly involved in virulence;
they are commonly transferred among bacterial
pathogens (Alsmark et al. 2004).
These results indicate strongly that recent gene
transfers are but the tip of a potentially very large
iceberg of gene transfers which over time have
fundamentally shaped the content of eukaryotic
genomes. LGT has thus produced numerous path-
ways and genes that are present in individual parasitic
protozoan species but that are not present on the
mammalian genome, thus providing a large and
variable pool of potential drug targets across proto-
zoan diversity.
Future perspectives
With an estimated number of more than 300,000
species of plants and more than a million species of
microorganisms, insects and marine organisms the
biodiversity of Nature remains an unparalleled reser-
voir of biological and chemical diversity.
Biological diversity, including the variety of life in
all its forms, will be of great importance in the future
to secure the access of a range of different organisms
for the survival of many people. The exploration of
the genetic and biochemical diversity of natural
resources can result in discovery of potential bioac-
tive compounds and development and sustainable
Fig. 9 Pathways predicted metabolic pathways of Entamoeba
histolytica based on analysis of its genome showing inferred
LGT (3). Glycolysis and fermentation are the major energy
generation pathways. Bold gray arrows represent enzymes
encoded by genes that are among the 68 candidates for HGT
into the Entamoeba histolytica genome. Broken arrows
indicate enzymes for which no gene could be identiﬁed from
the genome data, although the activity is thought to be present.
The framed arrow points to the target of Metronidazole, the
major drug for treatment of amoebic liver abscess. Abbrevi-
ations: PEP phosphoenolpyruvate, GlcNAc N-acetylglucosa-
mine, LCFA long chain fatty acid, VLCFA very long chain fatty
acid, PRPP phosphoribosyl pyrophosphate, GPI glycosylpho-
sphatidylinositol, PAPS phosphoadenosine phosphosulfate.
[reproduced from previous publication, permission requested]
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123utilisation of these resources. Complex mixtures of
natural products are marketed in the society as
pharmaceutical products in the form of botanical
drugs, nutraceuticals or even cosmeceuticals for
enhancement of health. Scientiﬁc methods need to
be developed for standardisation of bioactive com-
ponents of this type of products together with clinical
trials to prove the efﬁcacy and safety.
An increased understanding that micro-organisms,
found in or associated to different macro-organisms
both in terrestrial and marine organisms, are the true
producers of isolated novel compounds will result in
development of new methodology for cultivation of
such organisms and a sustainable resource for
bioactive natural products.
The growing number of resistant pathogenic
microorganisms due to an overuse of antibiotics and
the problem to treat severe infectious diseases will
accelerate the research to ﬁnd novel effective mol-
ecules of natural origin.
In an earlier publication we have proposed the
concept of molecular pharmacognosy, which
describes techniques and methods to characterize
the structure–activity reason for an observation in
Nature (e.g. Bruhn and Bohlin 1997; Bohlin et al.
2007). The ﬁeld of systems biology, which lies in line
with this approach, is an integrated way of studying
biological systems using several new technologies
such as genomics with transcriptomics, proteomics
and metabolomics. Applying these techniques will
generate a vast amount of data, which requires
informatics tools to be transformed into useful
biological information. In future studies of complex
mixtures of natural products these new techniques
can reveal the inﬂuence of phytochemicals on the
expression of genes that are involved in a speciﬁc
pharmacological function using microarrays, evalua-
tion of the enzymes involved in biosynthesis of
bioactive constituents in different organisms, and
correlation of the metabolic ﬁngerprint of a crude
extract to a speciﬁc biological activity.
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